Ccdc65 Gene Primary Ciliary Dyskinesia Type 27 NGS Genetic DNA Test

Introduction to the Test

The CCDC65 Gene Primary Ciliary Dyskinesia Type 27 NGS Genetic DNA Test is a specialized genetic test that aims to identify mutations in the CCDC65 gene, which is associated with primary ciliary dyskinesia (PCD). PCD is a genetic disorder that affects the cilia, the tiny hair-like structures that line the respiratory tract, leading to chronic respiratory issues and other complications. Understanding your genetic predisposition is essential for effective management and treatment.

What the Test Measures

This test specifically detects mutations in the CCDC65 gene, which can cause dysfunction in cilia movement. By analyzing DNA samples, the test helps in diagnosing primary ciliary dyskinesia, allowing for early intervention and management of the condition.

Who Should Consider This Test

Individuals experiencing chronic respiratory infections, sinusitis, or unexplained fertility issues should consider this test. Additionally, those with a family history of PCD or related symptoms may benefit from genetic testing.

Benefits of Taking the Test

• Early diagnosis of primary ciliary dyskinesia.
• Informed health decisions based on genetic predisposition.
• Guidance for potential treatment options and lifestyle adjustments.
• Understanding family planning options for at-risk individuals.

Understanding Your Results

After completing the test, results will indicate whether any mutations were detected in the CCDC65 gene. A genetic counselor will provide guidance on interpreting the results and discussing potential next steps based on your genetic profile.

Test Pricing

Book Your Test Today!

Don’t wait to understand your health better. Book the CCDC65 Gene Primary Ciliary Dyskinesia Type 27 NGS Genetic DNA Test today by calling or WhatsApping us at +2348077798758. Our dedicated team is ready to assist you with any inquiries and guide you through the booking process.